PubMed Health⌕ Search

PubMed · 7701235

Systematic reviews--theory and practice.

Abstract

The consumer of health care services experts that medical practice is based on scientific evidence with regard to efficacy and effectiveness. Randomized controlled trials provide the most valid basis for comparison of interventions in health care and offer the most reliable information to guide clinical practice. The need for well-designed and performed systematic reviews of the available information to address a specific clinical question should be obvious both to the practicing clinician and the consumer. A systematic review is defined as "the application of scientific strategies that limits bias to the systematic assembly, critical appraisal, and synthesis of all relevant studies on a specific topic". "Meta-analysis (quantitative overview) is a systematic review that employs statistical methods to combine and summarize the results of several trials". In a meta-analysis the individual studies are weighted according to the inverse of the variance; that is more weight is given to studies with more events. The pooling of data allows for an increase in power and thus a more precise estimate of the effect size. Systematic reviews that meet explicit criteria for validity offer the reader information that as a rule is less biased than the unstructured overview which has traditionally been performed by one or several experts in a specific content area. Recently statistical methods have been developed to summarize data from studies of diagnostic tests. Cumulative meta-analyses offer the caregiver and the health-care consumer with answers regarding the effectiveness of a certain intervention at the earliest possible date in time.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Ohlsson. 1994. Systematic reviews--theory and practice.. https://doi.org/10.3109/00365519409088573

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗